Cell and Gene Therapy Tools, and Reagents: Global Markets

Report Code: BIO208B

Publish Date: Nov 2022

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

Report Includes

  • 105 total tables
  • An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents
  • Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents
  • Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis
  • Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages
  • Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.

Report Scope

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $7.6 Billion
Market size forecast $13.8 Billion
Growth rate CAGR of 10.6% from 2022 to 2027
Units considered $ Million
Segments covered Type, Disease, End User
Regions covered North America, Europe, Asia Pacific, and Rest of the World (RoW)
Key Market Drivers
  • Increasing investments in CGT R&D
  • Increasing prevalence of chronic diseases
  • Increasing strategic collaborations and acquisitions
  • Increasing capacity expansions and manufacturing capabilities
Companies studied
ABCAM PLCAKRON BIOTECH
ADVERUM BIOTECHNOLOGIESATHERSYS INC.
AVROBIOBIO-RAD LABORATORIES INC.
BIO-TECHNECELLGENIX
CYTIVAFUJIFILM IRVINE SCIENTIFIC
LUMINEX CORP.MESOBLAST LTD.
MERCK KGAAMILTENYI BIOTEC
ORGANICELLPROTEINTECH GROUP INC.
SARTORIUS AGSINO BIOLOGICAL INC.
STEMCELL TECHNOLOGIESTHERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Cell and Gene Therapy Tools, and Reagents: Global Markets139Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background6Free
Chapter- 4: Market Dynamics8Free
Chapter- 5: Market Breakdown, by Application7Free
Chapter- 6: Market Breakdown, by End User8Free
Chapter- 7: Market Breakdown, by Type60Free
Chapter- 8: Market Breakdown by Region5Free
Chapter- 9: Government Regulations3Free
Chapter- 10: Patent Review/New Developments5Free
Chapter- 11: Competitive Landscape3Free
Chapter- 12: Company Profiles24Free
Published - Aug-2020| Analyst - Todd Graham| Code - BIO208A

Report Highlights

The global market for life science tools should grow from $6.5 billion in 2019 to reach $9.0 billion by 2024 at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2019-2024.

Report Includes

  • 77 data tables
  • An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
  • Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Information about in vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion on prevalence of infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
  • Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays and rapid diagnostic technologies
  • Evaluation of market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies

Related Reports

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Cell and Gene Therapy Manufacturing Services Market

Published - Aug 2023 | Publisher - BCC Publishing | Code - BIO245A

The global cell and gene therapy manufacturing services market reached $4.9 billion in 2022, should reach $5.7 billion by 2023 and $11.8 billion by 2028 with a compound annual growth rate (CAGR) of 15.7% during the forecast period of 2023-2028.

Thawing Systems: Global Markets

Published - May 2023 | Publisher - BCC Publishing | Code - MDS085A

The global market for thawing systems is estimated to increase from $242.2 million in 2022 to reach $341.4 million by 2027, at a compound annual growth rate (CAGR) of 7.1% from 2022 through 2027.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cell and Gene Therapy Tools, and Reagents: Global Markets
Sample Report